Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Valued EpiGenetic Glycemic ImprovEments Through Weight Loss

NCT02869659 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02869659 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Valued EpiGenetic Glycemic ImprovEments Through Weight Loss
Lead sponsor
Wake Forest University Health Sciences
Phase
Not applicable
Overall status
Completed
Start date
November 1, 2016
Completion date
December 2, 2020
Enrollment
138 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, pre-diabetes